A phase I clinical trial of intrapleural adenoviral-mediated interferon-beta (IFN-beta) gene transfer [BG00001] for pleural malignancies.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2010
At a glance
- Drugs Interferon-beta gene therapy (Primary)
- Indications Mesothelioma; Pleural effusion
- Focus Adverse reactions
- 11 Jul 2007 New trial record.